Dermatology · Washington, DC
NPI
1114312410
Since 2015
Specialty
Dermatology
Code 207N00000X
Group practices
2
Medicare group memberships
Hospitals
1
Hospital affiliations
2150 Pennsylvania Ave NW Ste 2b-430
Washington, DC, 20037
Phone (202) 741-3000
Groups this clinician bills Medicare through
Medicare paid, 2024
$296K
5,521 services
Medicare patients, 2024
369
Average age 72
Drug cost, 2024
$1.7M
808 prescriptions
Company payments, 2025
$11K
From 16 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Karl M Saardi was code 99214 (office e&m - established), 158 times for 130 patients. In total Karl M Saardi billed 5,521 services in 55 codes, and Medicare paid $296K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2020-06-30.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 158 | 130 | $95.99 | $15K |
| 99213 Office E&M - Established | Office | 134 | 120 | $68.18 | $9,136 |
| 99203 Office E&M - New | Office | 55 | 55 | $70.71 | $3,889 |
| 96372 Injection Administration | Office | 46 | 13 | $12.48 | $574 |
| 17003 Destruction Skin Lesion | Office | 46 | 19 | $6.06 | $279 |
| 11104 Skin Biopsy | Office | 39 | 38 | $91.56 | $3,571 |
| 17110 Destruction Skin Lesion | Office | 37 | 29 | $91.11 | $3,371 |
| 17000 Destruction Skin Lesion | Office | 35 | 29 | $47.84 | $1,674 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 33 | 32 | $10.80 | $356 |
| 99204 Office E&M - New | Office | 33 | 33 | $130.49 | $4,306 |
| 99212 Office E&M - Established | Office | 30 | 27 | $40.28 | $1,208 |
| 11102 Skin Biopsy | Office | 26 | 25 | $74.54 | $1,938 |
| J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 23 | 16 | $0.75 | $17.15 |
| 11900 Skin | Office | 20 | 15 | $47.42 | $948 |
| 99222 Hospital E&M - Initial | Facility | 17 | 17 | $110.76 | $1,883 |
By year: 2022 $537K for 12,496 services; 2023 $314K for 6,936 services; 2024 $296K for 5,521 services.
Medicare prescription drug claims, 2024
In 2024, the drug Karl M Saardi prescribed most often to Medicare patients was Triamcinolone Acetonide, with 82 prescriptions and refills. In total Karl M Saardi wrote 808 Medicare prescriptions that cost $1.7M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Triamcinolone Acetonide Generic | 82 | 95 | 44 | $866 |
| Dupixent Pen Dupilumab | 72 | 72 | 15 | $260K |
| Clobetasol Propionate Generic | 60 | 68 | 35 | $3,811 |
| Cosentyx Unoready Pen Secukinumab | 42 | 42 | Under 11 | $492K |
| Tacrolimus Generic | 37 | 39 | 14 | $4,015 |
| Clindamycin Phosphate Generic | 33 | 37 | Under 11 | $1,002 |
| Ketoconazole Generic | 32 | 54 | 16 | $399 |
| Zoryve Roflumilast | 26 | 31 | 11 | $22K |
| Ammonium Lactate Generic | 24 | 24 | Under 11 | $543 |
| Humira(Cf) Pen Adalimumab | 19 | 19 | Under 11 | $287K |
| Minoxidil Generic | 16 | 48 | Under 11 | $213 |
| Tretinoin Generic | 16 | 16 | Under 11 | $473 |
| Dutasteride Generic | 16 | 42 | Under 11 | $309 |
| Mometasone Furoate Generic | 16 | 17 | Under 11 | $232 |
| Remicade Infliximab | 15 | 15 | Under 11 | $144K |
Brand drugs: 272 claims; generic drugs: 521 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Karl M Saardi $11K ($11K in general payments such as food, travel and fees) from 16 companies. The largest payer was Boehringer Ingelheim Pharmaceuticals, Inc. with $9,699.
| Company | Payments | Amount |
|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | 9 | $9,699 |
| Janssen Biotech, Inc. JNJ | 4 | $312 |
| Abbvie Inc. ABBV | 12 | $160 |
| UCB, Inc. UCB.BR | 4 | $97.27 |
| Sun Pharmaceutical Industries Inc. SUNPHARMA.NS | 1 | $36.96 |
| SpringWorks Therapeutics, Inc. | 2 | $35.04 |
| Lilly USA, LLC LLY | 1 | $29.43 |
| Pfizer Inc. PFE | 2 | $28.83 |
| Organon LLC OGN | 1 | $27.67 |
| Regeneron Healthcare Solutions, Inc. REGN | 1 | $22.56 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.